Nonalcoholic Steatohepatitis (NASH) is a liver disease characterized by inflammation and damage to the liver, which can progress to cirrhosis, liver failure, or even liver cancer if left untreated. The increasing global prevalence of NASH, largely driven by rising rates of obesity and diabetes, has prompted significant advancements in the development of NASH treatment options. Despite...